Select a community
MSA
Find out more about the PatientsLikeMe
MSA Community
Home > Community Treatment Reports > Pramipexole Treatment Report
What is Pramipexole?

Pramipexole is an anti-Parkinson's agent that is used to treat symptoms of Parkinson's Disease, such as stiffness, tremors, muscle spasms, and poor muscle control and for moderate to severe primary restless legs syndrome. Off label it is used for the treatment of depression.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
tremor, hand 4 1
Treat my MSA 1 0
Restless Legs Syndrome (RLS) 1 0
Other 1 0
Stiffness 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 100%
None
0 0%

Most commonly reported side effects

Drowsiness
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  0.125 mg daily 0.375 mg daily 1 mg daily 3 mg daily 4 mg daily 4.5 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3  

Stop Reasons

Why Patients Stopped Taking Pramipexole (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
1 100% Side effects too severe: 100%

See all 1 patient who’ve stopped taking Pramipexole

Currently Taking Pramipexole

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
2
2
0

Stopped Taking Pramipexole

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 100%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.